Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
- Triggering Signals of BRCA1 Breast Cancer (K Kessenbrock)
- Testing Diverse Groups Finds New Breast Cancer Genes (L Teras)
- Black Women & Genetic Testing (J Palmer)
- Women 65+ & Genetic Tests for Breast Cancer Risk (L Teras)
- High-Risk Genes and Screening (A Patel)
- New Risk Calculation May Affect Breast Cancer Screening (L Teras)
- Black Men and Breast Cancer (H Sung)
- Platelets May Help Breast Cancer Spread (E Battinelli)
- Natural Killer Cells & TNBC (R. Chakrabarti)
- Improving Chemotherapy (O Sahin)
- Combo Treatment for TNBC (K Varley)
- Treatments Attack Cell Division (A Holland)
- ER+ Treatment in Mice (P Kenny)
- Blood DNA Monitors Metastasis Treatment (H P Ji)
- PTK6 Gene as Treatment Target (H Irie)
- Time-Lapse Cell Movies (S Spencer)
- 3D Mini Breast Tumors May Help ID New Cancer Treatments
- AI Tool Improves Breast Cancer Prognosis Accuracy
- Exercise & Sitting Time (E. Rees-Punia)
- Cancer Risk Factors in LGBTQ Populations (B. Charlton)
- CPS-3 Disparities Studies
- Cancer Disparities in the US (F. Islami)
- Housing Assistance and Mammograms (H Lee)
- Clinical Trial Treatment Cost App (L Hamel)
- Podcasts, TheoryLab
- Patients Health Insurance Tool (M. Politi)
- Breast Cancer Treatment in Ethiopia (A. Jemal)
- Better Survival Requires Better Insurance (J Zhao)
- Medicaid Eligibility Limits (J Zhao)
- New Treatment for Neuroblastoma (A Heczey)
- Oncogenic Fusions AML (S Meshinchi)
- Genetic Risks (L Teras)
- New Medulloblastoma Drugs (J Rodriguez-Blanco)
- Potential New Hope for MLL (J Grembecka)
- Increase in Brain Tumor Diagnosis (K Miller)
- Longer Life Expectancy for Survivors (J Yeh)
- Potential Target for New Osteosarcoma Drugs (C Benavente)
- At-Home Chemo for Children with HR ALL (L Ranney)
- Childhood Cancer Research Landscape Report
- Tumor-Infiltrating Neutrophils (R. Sumagin)
- New Epigenetic Target (K Rai)
- Extra Chromosomes (Aneuploidy) Effect on Cancer (J. Sheltzer)
- Discovery of a New Biomarker Is the First Step to New Treatment (C. Maher)
- Designer Virus Targets and Kills CRC Cells in Mice (S. Warner)
- Tiny Sensor in Mice May Find Cancer That's Trying to Spread (L. Hao)
- Targeting a Protein “Turned on” by Mistake (N. Gao)
- Spatial Map Intestines (J Hickey)
- CRC Treatment Podcasts
- Keto Molecule & Colorectal Cancer (M Levy)
- Availability of Healthy Food (L Tussing-Humphreys)
- 45 Min/Day of Physical Activity (A Minihan)
- Fewer than 10K Steps/Day (A Patel)
- Yogurt & Cheese & ER- Breast Cancer (M McCullough)
- Stage 2 Clinical Trials for New Endometrial Cancer Drug (V Bae-Jump)
- Hard-to-Starve Pancreatic Cancer Cells (N Kalaany)
- Coffee Risks for Colorectal Cancer (C Um)
- Food Parasite & Brain Cancer Risk (J Hodge)
- Exercise & Quality of Life in Older Survivors (E Rees-Punia)
- 21 Metabolites Linked with Breast Cancer (Y Wang)
- Replacing Sitting May Affect Weight (E Rees-Punia)
- CPS-3 Researchers Ask What People Eat and Check Urine Samples (Y Wang)
- Video Games Motivate Exercise? (E. Lyons)
- Food Choices and Colon Cancer Risk (P. Chandler)
- Race, Exercise & Breast Cancer (C. Dallal)
- Diet with Colorectal Cancer (M. Guinter)
- Biomarkers May Improve Prediction (Y Wang)
- Kickstart NSCLCs Clinical Trials (L. Eichner)
- Mapping Mitochondria's “Dance” (D. Shackleford)
- E-Cig Use Ages 18 to 29 (P. Bandi)
- Stopping Smoking Earlier in Life (F Islami)
- Most with Lung Cancer Smoked (A Jemal)
- Furthering Lung Cancer Screening & Equity (S Fedewa)
- Mouse Lung Organoids for Research (C Kim)
- Quality of Life for Lung Cancer Survivors (J Temel)
- Precision Therapies for NSCLC (P Jänne)
- Cancer Deaths from Smoking (F Islami)
- Lung Cancer Surgery Disparities (A Jemal)
- BRG1-Deficient Lung Cancers (C Kim)
- Yoga for Couples with Lung Cancer (K Milbury)
- Metabolic Differences as New Drug Targets (A Marcus)
- CPS-II & CPS-3 Inform About Risks of Ovarian Cancer
- Machine Learning & Glowing Nanosensors (D Heller)
- Ovarian Cancer May Start in Fallopian Tube Cells (K Lawrenson)
- New Gene Linked with Deadliest Type (C Han)
- Gene-Testing Tools May Personalize Care (A Sood)
- Chromosome-Hoarding Ovarian Cancer Cells & Treatment (J Sheltzer)
- Nanoparticles as Drug Delivery for Metastases (X Lu)
- Turning Off 2 Proteins to Slow HGSC (P Kreeger)
- Targeted Light Therapy in Mice (M Bai)
- Nanoparticles, CAR T, and CRISPR (M Stephan)
- Endometriosis & Ovarian Cancer in Mice (M Wilson)
- Ovarian Cancer Special Section
- UV Exposure, Melanoma, & Dark Skin Types (A. Adamson)
- Melanoma and Lipid Droplets (R. White)
- Zebrafish and Acral Melanoma (R. White)
- T-Cell Lymphoma and PD1 (J. Choi)
- New Drug Destroys Cancer-Causing Protein (C. Crews)
- Virus & Merkel Cell Skin Cancer (R. Wang)
- Non-Genetic Drug Resistance (S. Spencer)
- Hijacking the Body's Sugar (R. Wang)
- Telling about High Risk (P. Kanetsky)
- Brain Metastasis and Alzheimer’s (E. Hernando)
- Exhausted Melanoma "Killer" Cells (W. Cui)
Poverty Has a High Cost for Breast Cancer Survivors
Study shows that, for women age 65 and older with breast cancer, poverty has a greater affect on survival than whether they live in a rural or urban area.
The Challenge
In the United States, people who live in a rural area may have different challenges accessing cancer care than those who live in an urban area. One problem may be workforce shortages for health care staff in rural counties. For instance, while 20% of the US population lives in a rural area, those areas are only served by 3% of oncologists. Specialists in fields other than oncology are also more likely to have offices in urban settings.
The challenges can be worse if the person needing cancer care is experiencing poverty.
Mortality rates for people diagnosed with breast cancer is known to be affected by the rural versus urban divide, with those living in rural settings having higher rates. What hasn’t been studied is how these issues affect people over age 65 who have breast cancer.
The Research
Kelly Kenzik, PhD, and colleagues specifically looked at Medicare data for women age 65 and older who were diagnosed with breast cancer between January 2000 and December 2011. They focused on how income and location affect use of the health care system and survival.
The concept of ‘place-based’ health has become increasingly important in cancer research. Where people live has emerged as a critical component to consider when evaluating their risks for developing cancer, getting adequate treatment for cancer, and short- and long-term survival after a cancer diagnosis. Our study highlighted that a singular factor—rural residence—can not accurately evaluate risks for cancer outcomes. Now my research team is seeking to fully examine the characteristics of a person’s environment—including rurality, poverty, access to care, transportation, and community resources—and how these interplay with personal factors to affect cancer outcomes.”
Kelly M. Kenzik, PhD
University of Alabama, Birmingham
ACS Grantee
To get the data they needed, Kenzik’s researchers captured patients’ Medicare claims from one year before diagnosis to establish pre-existing conditions through December 2013 or death, whichever occurred first. They tracked visits to primary care providers, oncologists, non-oncology specialists, and the emergency department.
When more than 20% of people living in an area had incomes below the Federal Poverty Level (FPL), Kenzik defined the area as a high poverty one. Less than 10% of the population had an income below the FPL in “low-poverty” areas.
Here are some of their key findings.
Poverty is more strongly related to 5-year survival rates for people with breast cancer over age 65 than their area of residence. The authors found that after a diagnosis of breast cancer, women who were living in a low poverty area, whether it was urban or rural, had a 5-year survival rate of 74%.
In comparison, people living in high-poverty areas had much lower 5-year survival rates, with those in rural areas having a 66% 5-year survival rate and those in urban areas having a 63% survival rate.
Factors contributing to these lower survival rates may differ by location of residence. Studies report that rural residence is associated with delays in diagnosis. Such delays mean women are more likely to be diagnosed with cancer at a later stage, when treatment is less likely to cure the cancer.
For urban, high-poverty residences, studies show patients were more likely to be Black and have more health problems in addition to cancer (comorbidities) than White women in those areas. Previous evidence has shown that Black women with early-stage breast cancer are less likely to receive treatment, more likely to discontinue therapy, and have worse survival outcomes than White women.
Compared to older breast cancer patients living in urban areas (with low- or high- poverty levels), patients living with high poverty in rural areas:
- Visited primary care physicians and emergency rooms more frequently
- Had no significant differences in the frequency of visits to oncologists (in contrast to previous research)
Regardless of their location, breast cancer patients living in a high-poverty area had more health problems in addition to cancer (comorbidities) than people living in areas where more people had higher incomes. Interestingly, Kenzik found that patients living in high poverty areas had a lower rate of non-oncology specialist visits, even though treatment for comorbidities relies on care from non-oncology specialists.
Why It Matters
Overall, the authors found that for older breast cancer patients, where they lived had less of an effect on their survival than their socioeconomic status. Continued research is needed to better understand why outcomes differ in these communities and what might be done to decrease the disparities.